Medpace Holdings Share Holder Equity 2014-2025 | MEDP
Medpace Holdings share holder equity from 2014 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Medpace Holdings share holder equity for the quarter ending March 31, 2025 was $0.594B, a 11.61% decline year-over-year.
- Medpace Holdings share holder equity for 2024 was $0.826B, a 47.7% increase from 2023.
- Medpace Holdings share holder equity for 2023 was $0.559B, a 44.66% increase from 2022.
- Medpace Holdings share holder equity for 2022 was $0.386B, a 59.45% decline from 2021.
| Medpace Holdings Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $826 |
| 2023 | $559 |
| 2022 | $386 |
| 2021 | $953 |
| 2020 | $806 |
| 2019 | $726 |
| 2018 | $590 |
| 2017 | $504 |
| 2016 | $611 |
| 2015 | $413 |
| 2014 | $402 |
| 2013 | $0 |
| Medpace Holdings Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $594 |
| 2024-12-31 | $826 |
| 2024-09-30 | $881 |
| 2024-06-30 | $764 |
| 2024-03-31 | $672 |
| 2023-12-31 | $559 |
| 2023-09-30 | $471 |
| 2023-06-30 | $391 |
| 2023-03-31 | $347 |
| 2022-12-31 | $386 |
| 2022-09-30 | $350 |
| 2022-06-30 | $283 |
| 2022-03-31 | $605 |
| 2021-12-31 | $953 |
| 2021-09-30 | $898 |
| 2021-06-30 | $852 |
| 2021-03-31 | $859 |
| 2020-12-31 | $806 |
| 2020-09-30 | $792 |
| 2020-06-30 | $738 |
| 2020-03-31 | $718 |
| 2019-12-31 | $726 |
| 2019-09-30 | $692 |
| 2019-06-30 | $658 |
| 2019-03-31 | $622 |
| 2018-12-31 | $590 |
| 2018-09-30 | $561 |
| 2018-06-30 | $540 |
| 2018-03-31 | $511 |
| 2017-12-31 | $504 |
| 2017-09-30 | $550 |
| 2017-06-30 | $607 |
| 2017-03-31 | $621 |
| 2016-12-31 | $611 |
| 2016-09-30 | $611 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2014-12-31 | $402 |
| 2013-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.622B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.189B | 25.92 |
| Elevance Health (ELV) | United States | $94.312B | 12.17 |
| CVS Health (CVS) | United States | $84.478B | 10.50 |
| Cencora (COR) | United States | $59.063B | 20.54 |
| Natera (NTRA) | United States | $21.643B | 0.00 |
| DiDi Global (DIDIY) | China | $20.379B | 30.93 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.707B | 0.00 |
| Solventum (SOLV) | United States | $11.330B | 10.56 |
| ICON (ICLR) | Ireland | $11.213B | 10.42 |
| CochLear (CHEOY) | Australia | $11.158B | 0.00 |
| Doximity (DOCS) | United States | $10.895B | 56.66 |
| Revvity (RVTY) | United States | $10.796B | 18.58 |
| Viatris (VTRS) | United States | $10.198B | 3.25 |
| Sonic Healthcare (SKHHY) | Australia | $8.157B | 0.00 |
| Avantor (AVTR) | United States | $8.136B | 11.82 |
| HealthEquity (HQY) | United States | $7.933B | 39.03 |
| Charles River Laboratories (CRL) | United States | $6.727B | 13.18 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.028B | 23.75 |
| BrightSpring Health Services (BTSG) | United States | $4.015B | 37.16 |
| Sotera Health (SHC) | United States | $3.733B | 21.21 |
| Alignment Healthcare (ALHC) | United States | $3.071B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.969B | 34.06 |
| Concentras Parent (CON) | United States | $2.803B | 16.20 |
| Organon (OGN) | United States | $2.277B | 2.42 |
| Premier (PINC) | United States | $2.111B | 14.45 |
| Ardent Health Partners (ARDT) | United States | $2.028B | 8.66 |
| Progyny (PGNY) | United States | $2.006B | 44.19 |
| GeneDx Holdings (WGS) | United States | $1.609B | 63.01 |
| PACS (PACS) | United States | $1.603B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.454B | 27.07 |
| Agilon Health (AGL) | United States | $1.403B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.233B | 9.38 |
| Teladoc Health (TDOC) | United States | $1.203B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.960B | 0.00 | |
| CareDx (CDNA) | United States | $0.822B | 12.84 |
| AMN Healthcare Services Inc (AMN) | United States | $0.749B | 5.92 |
| Embecta (EMBC) | United States | $0.725B | 4.97 |
| QDM (QDMI) | Hong Kong, SAR China | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.649B | 12.72 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 13.73 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.440B | 0.00 |
| Enhabit (EHAB) | United States | $0.415B | 34.17 |
| LifeMD (LFMD) | United States | $0.364B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.347B | 0.00 |
| SBC Medicals (SBC) | United States | $0.332B | 0.00 |
| DocGo (DCGO) | United States | $0.245B | 10.00 |
| Oncology Institute (TOI) | United States | $0.208B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.179B | 0.00 |
| Beauty Health (SKIN) | United States | $0.178B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.75 |
| KindlyMD (KDLY) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |